Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins

[1]  Diane D. Liu,et al.  Expression of ΔDNMT3B Variants and Its Association with Promoter Methylation of p16 and RASSF1A in Primary Non–Small Cell Lung Cancer , 2006 .

[2]  S. Jang,et al.  A novel DNMT3B subfamily, DeltaDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer. , 2006, International journal of oncology.

[3]  M. Grever,et al.  Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. , 2006, Cancer research.

[4]  S. Stamm,et al.  Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene. , 2006, Cancer research.

[5]  Christian B. Woods,et al.  Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors , 2006, Oncogene.

[6]  R. Jaenisch,et al.  Suppression of Intestinal Neoplasia by Deletion of Dnmt3b , 2006, Molecular and Cellular Biology.

[7]  E. Li,et al.  Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome , 2006, Development.

[8]  A. Chan.  E-cadherin in gastric cancer. , 2006, World journal of gastroenterology.

[9]  P. Guldberg,et al.  Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early‐stage patients , 2006, European journal of haematology.

[10]  A. Stein,et al.  Histone H1 Depletion in Mammals Alters Global Chromatin Structure but Causes Specific Changes in Gene Regulation , 2005, Cell.

[11]  S. Matsui,et al.  Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. , 2005, Cancer research.

[12]  T. Rowlands,et al.  Cadherins and catenins in breast cancer. , 2005, Current opinion in cell biology.

[13]  R. Jaenisch,et al.  Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Robertson.  DNA methylation and human disease , 2005, Nature Reviews Genetics.

[15]  J. Venables.  Aberrant and Alternative Splicing in Cancer , 2004, Cancer Research.

[16]  K. Robertson,et al.  DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation system. , 2004, Biochemical and biophysical research communications.

[17]  Keith D Robertson,et al.  Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery. , 2004, Nucleic acids research.

[18]  M. Ehrlich.  The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. , 2003, Clinical immunology.

[19]  R. Hansen,et al.  X inactivation-specific methylation of LINE-1 elements by DNMT3B: implications for the Lyon repeat hypothesis. , 2003, Human molecular genetics.

[20]  M. Schrappe,et al.  Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia , 2003, Nature.

[21]  O. Haas,et al.  Differential methylation pattern of the X-linked lymphoproliferative (XLP) disease gene SH2D1A correlates with the cell lineage-specific transcription , 2003, Immunogenetics.

[22]  R. Jaenisch,et al.  Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.

[23]  S. Hirohashi,et al.  Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers. , 2003, Cancer letters.

[24]  K. Maruyama,et al.  The human DNA methyltransferases DNMT3A and DNMT3B have two types of promoters with different CpG contents. , 2002, Biochimica et biophysica acta.

[25]  Y. Fukushima,et al.  Three novel DNMT3B mutations in Japanese patients with ICF syndrome. , 2002, American journal of medical genetics.

[26]  E. Li.  Chromatin modification and epigenetic reprogramming in mammalian development , 2002, Nature Reviews Genetics.

[27]  M. Caligiuri,et al.  RasGRP4 Is a Novel Ras Activator Isolated from Acute Myeloid Leukemia* , 2002, The Journal of Biological Chemistry.

[28]  K. Robertson.  DNA methylation and chromatin – unraveling the tangled web , 2002, Oncogene.

[29]  C. J. Barnes,et al.  A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm , 2002, Nature.

[30]  M. Robert,et al.  An Essential Role for DNA Methyltransferase DNMT3B in Cancer Cell Survival* , 2002, The Journal of Biological Chemistry.

[31]  R. Roberts,et al.  Co‐operation and communication between the human maintenance and de novo DNA (cytosine‐5) methyltransferases , 2002, The EMBO journal.

[32]  A. Sali,et al.  RasGRP4, a New Mast Cell-restricted Ras Guanine Nucleotide-releasing Protein with Calcium- and Diacylglycerol-binding Motifs , 2002, Journal of Biological Chemistry.

[33]  S. Hirohashi,et al.  Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Cooper,et al.  Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. , 2002, Molecular cell.

[35]  H. Taubert,et al.  Alternative and aberrant splicing of MDM2 mRNA in human cancer. , 2002, Cancer cell.

[36]  A. Shyu,et al.  RNA surveillance by nuclear scanning? , 2002, Nature Cell Biology.

[37]  Bert Vogelstein,et al.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.

[38]  M. Maio,et al.  Promoter Methylation Controls the Expression of MAGE2, 3 and 4 Genes in Human Cutaneous Melanoma , 2002, Journal of immunotherapy.

[39]  J. Chung,et al.  Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1. , 2001, Biochemical and biophysical research communications.

[40]  J. Herman,et al.  DNA methylation, chromatin inheritance, and cancer , 2001, Oncogene.

[41]  T. Bestor,et al.  The DNA methyltransferases of mammals. , 2000, Human molecular genetics.

[42]  J. Herman,et al.  CpG methylation is maintained in human cancer cells lacking DNMT1 , 2000, Nature.

[43]  C. Wijmenga,et al.  The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  N. Tommerup,et al.  Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene , 1999, Nature.

[45]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[46]  M. Culbertson,et al.  RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer. , 1999, Trends in genetics : TIG.

[47]  S. Clark,et al.  High sensitivity mapping of methylated cytosines. , 1994, Nucleic acids research.

[48]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[49]  M. Robert,et al.  DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells , 2003, Nature Genetics.

[50]  J. Herman,et al.  Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. , 2003, Cancer cell.

[51]  D. Riesner,et al.  Induction of Tumors in Mice by Genomic Hypomethylation , 2003 .

[52]  C. J. Barnes,et al.  A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm. , 2002, Nature.

[53]  K. Robertson,et al.  The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. , 1999, Nucleic acids research.